Taiyu Capital, a corporate venturing unit of TigerMed, is among the investors in a round that increased the concussion response specialist's total funding to $13m.
US-based medical device startup Neural Analytics has raised $10m in a series A round featuring clinical development services provider TigerMed, which invested through its Taiyu Capital subsidiary.
The round also included venture capital fund JSR, and follows $3m of seed funding raised between April 2014 and October 2015.
Neural Analytics is working on technology that will combine data science and medical robotics to measure, diagnose and track brain health, and in particular traumatic brain injury conditions such as concussions.
The technology was originally developed in the University of California, Los Angeles’ neurology department.
Leo Petrossian, co-founder and CEO of Neural Analytics, said: “This remarkable level of interest and significant capitalisation demonstrates high confidence in our team and the excitement around the launch of our clinical trials early next year.”
– This article first appeared on our sister site Global Corporate Venturing.
